Acquisition Strengthens Aspire Pharma’s Strategic Portfolio
Petersfield, Hampshire, 4 October 2024: Aspire Pharma Limited, a high growth UK-based specialty niche generics business, announces the further strengthening of its product portfolio through the acquisition of all assets from Canute Pharma Limited. The acquisition underpins Aspire’s commitment to continue to make a difference in the lives of patients
